Cephalon (CEPH) Trades Down Slightly After Rejecting Valeant's (VRX) Offer
Tweet
Share
E-mailGet Alerts CEPH Hot Sheet
Join SI Premium – FREE
Cephalon, Inc. (NASDAQ: CEPH) is trading down slightly to $76.76 after formally rejecting a Valeant Pharmaceuticals (NYSE: VRX) $73 takeover bid. Shares closed at $77.37 today.
Valent is down 0.9% to $53.50.
Valent is down 0.9% to $53.50.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Holcim said to acquire part of James Hardie's EU business
- NVIDIA (NVDA) in talks to invest in data-center company Cloverleaf Infrastructure - WSJ
- Buyout firm Vista explores $3B sale of private markets data provider Allvue - Reuters
Create E-mail Alert Related Categories
Mergers and Acquisitions, Trader Talk, Trading HaltsRelated Entities
Valeant Pharmaceuticals/Cephalon, Inc.Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
